SCHEMBL7655088

SCHEMBL7655088

COc1ccc(CNC(=O)c2cc(Cl)ccc2N)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.55
MDM2 Q00987 1/20 0.55
HPGD P15428 4/20 0.54
ALDH1A1 P00352 4/20 0.54
KDM4E B2RXH2 1/20 0.54
USP2 O75604 1/20 0.54
MAPT P10636 2/20 0.54
NPC1 O15118 2/20 0.53
RAB9A P51151 2/20 0.53
KLKB1 P03952 1/20 0.53
LMNA P02545 1/20 0.53
GABRP O00591 1/20 0.52
GABRD O14764 1/20 0.52
GABRA1 P14867 1/20 0.52
GABRB1 P18505 1/20 0.52
GABRG2 P18507 1/20 0.52
GABRB3 P28472 1/20 0.52
GABRA5 P31644 1/20 0.52
GABRA3 P34903 1/20 0.52
GABRA2 P47869 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7649475 0.90 TP53 (0.55) TP53MDM2HPGDALDH1A1KDM4E
SCHEMBL29699281 0.86 TP53 (0.54) TP53MDM2HPGDALDH1A1KDM4E
SCHEMBL7648349 0.86 HPGD (0.59) TP53HPGDALDH1A1KDM4EUSP2
SCHEMBL6296069 0.86 NPC1 (0.60) TP53HPGDALDH1A1KDM4EUSP2
SCHEMBL8292287 0.84 GAA (0.57) HPGDALDH1A1KDM4EUSP2LMNA
SCHEMBL8300733 0.84 LMNA (0.55) HPGDALDH1A1KDM4EUSP2LMNA
SCHEMBL17241538 0.84 TP53 (0.56) TP53MDM2HPGDALDH1A1MAPT
SCHEMBL6302831 0.84 NPC1 (0.56) HPGDALDH1A1KDM4EUSP2NPC1
SCHEMBL3359400 0.82 HPGD (0.63) HPGDALDH1A1KDM4EUSP2MAPT
SCHEMBL8301468 0.82 POLB (0.51) HPGDALDH1A1KDM4EUSP2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6407116-B1 2,4-DIOXO-1,2,3,4-TETRAHYDROQUINAZOLINE DERIVATIVES; ANTIALLERGENS, ANTIASTHMATICS, ANTIHISTAMINES, AND ANTIINFLAMMATORY AGENTS TAKEDA CHEMICAL INDUSTRIES, INC. (JP) 2002-06-18 US disclosed
EP-1026160-A1 NITROGENOUS FUSED-RING COMPOUNDS, PROCESS FOR THE PREPARATION OF THE SAME, AND DRUGS Takeda Chemical Industries, Ltd. (JP) 2000-08-09 EP disclosed